Cubist Systematic Strategies, LLC Cytom X Therapeutics, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 24,460 shares of CTMX stock, worth $24,460. This represents 0.0% of its overall portfolio holdings.

Number of Shares
24,460
Previous 82,054 70.19%
Holding current value
$24,460
Previous $100,000 72.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$1.12 - $1.51 $64,505 - $86,966
-57,594 Reduced 70.19%
24,460 $28,000
Q2 2024

Aug 14, 2024
BUY
$1.21 - $5.13 $48,773 - $206,785
40,309 Added 96.56%
82,054 $100,000
Q1 2024

May 15, 2024
BUY
$1.41 - $2.74 $58,860 - $114,381
41,745 New
41,745 $91,000
Q3 2021

Nov 15, 2021
SELL
$4.32 - $6.43 $691 - $1,028
-160 Reduced 1.68%
9,346 $48,000
Q1 2021

May 17, 2021
SELL
$6.6 - $9.0 $187,050 - $255,069
-28,341 Reduced 74.88%
9,506 $73,000
Q4 2020

Feb 16, 2021
BUY
$6.47 - $7.9 $89,305 - $109,043
13,803 Added 57.41%
37,847 $248,000
Q3 2020

Nov 16, 2020
BUY
$6.55 - $8.83 $116,321 - $156,811
17,759 Added 282.56%
24,044 $160,000
Q2 2020

Aug 14, 2020
SELL
$7.4 - $14.64 $54,545 - $107,911
-7,371 Reduced 53.98%
6,285 $52,000
Q1 2020

May 15, 2020
BUY
$3.61 - $8.6 $25 - $60
7 Added 0.05%
13,656 $105,000
Q4 2019

Feb 14, 2020
BUY
$5.17 - $8.91 $70,565 - $121,612
13,649 New
13,649 $113,000
Q3 2019

Nov 14, 2019
SELL
$7.38 - $12.25 $345,229 - $573,042
-46,779 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$9.35 - $11.41 $295,469 - $360,567
31,601 Added 208.2%
46,779 $525,000
Q1 2019

May 15, 2019
SELL
$9.5 - $19.16 $225,796 - $455,394
-23,768 Reduced 61.03%
15,178 $163,000
Q4 2018

Feb 14, 2019
BUY
$12.69 - $18.61 $177,951 - $260,968
14,023 Added 56.27%
38,946 $588,000
Q3 2018

Nov 14, 2018
BUY
$18.04 - $26.41 $299,427 - $438,353
16,598 Added 199.38%
24,923 $461,000
Q2 2018

Aug 14, 2018
SELL
$21.38 - $29.68 $272,680 - $378,538
-12,754 Reduced 60.51%
8,325 $190,000
Q1 2018

May 15, 2018
SELL
$21.76 - $34.22 $122,900 - $193,274
-5,648 Reduced 21.13%
21,079 $600,000
Q4 2017

Feb 14, 2018
BUY
$19.0 - $23.09 $507,813 - $617,126
26,727
26,727 $564,000

Others Institutions Holding CTMX

# of Institutions
68
Shares Held
50.4M
Call Options Held
112K
Put Options Held
8.3K
View Full List

About CytomX Therapeutics, Inc.

CTMX Quotes by TradingView
  • Ticker CTMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,950,200
  • Market Cap $66M
  • Description
  • CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...
More about CTMX
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email